Recombinant filaggrin polypeptides for cell importation

US10336797B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10336797-B2
Application numberUS-201013511267-A
CountryUS
Kind codeB2
Filing dateNov 22, 2010
Priority dateNov 23, 2009
Publication dateJul 2, 2019
Grant dateJul 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are recombinant polypeptides that include (a) a filaggrin amino acid sequence and (b) a cell importation signal sequence that includes a motif of two to fifteen amino acids, wherein the motif includes at least one arginine residue and at least one methionine residue. Also disclosed are nucleic acids encoding the recombinant polypeptides of the present invention, and compositions that include the recombinant polypeptides and nucleic acids of the present invention. Methods of treating or preventing a skin disease or skin disorder using the compositions of the present invention are also included, as well as kits that include a sealed containing that includes a recombinant polypeptide of the present invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A recombinant polypeptide comprising (a) a filaggrin amino acid sequence; and (b) a cell importation signal sequence comprising a motif of two to fifteen amino acids, wherein the motif comprises at least one arginine residue and at least one methionine residue, wherein the polypeptide comprises SEQ ID NO:21 or SEQ ID NO:22. 2. The polypeptide of claim 1 , wherein the polypeptide consists of SEQ ID NO:21 or SEQ ID NO:22. 3. A skin-care composition comprising an effective amount of a polypeptide as set forth in claim 1 . 4. The composition of claim 3 , comprising a lipid component. 5. The composition of claim 4 , wherein the lipid component comprises a phospholipid. 6. The composition of claim 3 , wherein the composition is a solution, an emulsion, a cream, a lotion, a gel, or an ointment. 7. The composition of claim 6 , wherein the emulsion is an oil-in-water emulsion or a water-in-oil emulsion. 8. The composition of claim 3 , wherein the composition comprises from about 0.001% to about 5.0% by weight of polypeptide. 9. A nucleic acid comprising a nucleic acid sequence encoding a polypeptide as set forth in claim 1 . 10. A pharmaceutical composition comprising a polypeptide as set forth in claim 1 . 11. A method of treating a skin disease or skin disorder selected from the group consisting of ichthyosis, eczema and dermatitis comprising applying an effective amount of the composition of claim 10 to affected skin of a subject in need of such treatment. 12. The method of claim 11 , wherein the subject is a human. 13. The method of claim 11 , wherein the skin disease is ichthyosis vulgaris or atopic dermatitis. 14. The method of claim 11 , wherein the composition is topically applied to a skin surface of the subject. 15. The method of claim 11 , wherein the composition further comprises one or more additional agents that can be applied in the treatment of the skin disease or disorder in the subject. 16. The method of claim 11 , wherein the additional agent is a moisturizer, an exfoliating agent, an anti-inflammatory agent, or an antimicrobial agent. 17. A kit comprising a sealed container comprising the composition of claim 10 . 18. The kit of claim 17 , wherein the sealed container is a vial, a bottle, a dispenser, or a package. 19. The kit of claim 17 , further comprising an applicator.

Assignees

Inventors

Classifications

  • Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Proteins; Peptides; Derivatives or degradation products thereof · CPC title

  • for chemically tanning the skin (topical sun or radiation screening or tanning preparations A61Q17/04) · CPC title

  • Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10336797B2 cover?
Disclosed are recombinant polypeptides that include (a) a filaggrin amino acid sequence and (b) a cell importation signal sequence that includes a motif of two to fifteen amino acids, wherein the motif includes at least one arginine residue and at least one methionine residue. Also disclosed are nucleic acids encoding the recombinant polypeptides of the present invention, and compositions that …
Who is the assignee on this patent?
Stout J Timothy, Appukuttan Binoy, Mcfarland Trevor, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07K14/4713. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).